Cranford, NJ, United States of America

Dann LeRoy Parker, Jr

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 7.9

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Cranford, NJ (US) (2006 - 2019)
  • Rahway, NJ (US) (2019)

Company Filing History:


Years Active: 2006-2019

Loading Chart...
Loading Chart...
12 patents (USPTO):

Title: Dann LeRoy Parker, Jr.: A Pioneer in Pharmaceutical Innovations

Introduction

Dann LeRoy Parker, Jr., an inventive mind based in Cranford, NJ, has made significant contributions to the field of pharmaceuticals with a portfolio of 12 patents. His groundbreaking work focuses on developing compounds that target critical biological processes, paving the way for new treatments in oncology and coagulation disorders.

Latest Patents

Among Parker's most recent inventions are tricyclic compounds designed to inhibit mutant isocitrate dehydrogenase (IDH) enzymes. These compounds have the potential to be used in the treatment or prevention of various cancers linked to mutant IDH enzymes. Additionally, Parker has developed selective inhibitors for Factor XIa, aimed at treating or preventing thromboses, embolisms, and related conditions. These innovations represent a promising advancement in therapeutic options for patients with serious health issues.

Career Highlights

Throughout his career, Parker has honed his expertise while working with notable pharmaceutical companies, including Merck Sharp & Dohme Corporation and Merck & Company, Inc. His role in these organizations has enabled him to translate innovative concepts into practical applications, significantly enhancing the potential for effective medical treatments.

Collaborations

Parker's journey in innovation has been enriched through collaborations with esteemed colleagues, such as Robert R. Wilkening and Kenneth J. Wildonger. Working alongside such accomplished professionals has fostered a thriving environment for creativity and the exchange of ideas, further driving the impact of his inventions.

Conclusion

Dann LeRoy Parker, Jr.'s contributions to the pharmaceutical industry exemplify the spirit of innovation. By combining scientific knowledge with practical applications, Parker continues to pave the way for advancements in cancer treatment and blood coagulation management. His work not only reflects personal achievement but also holds the promise of improving countless lives through new medical interventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…